Dan Kemp, Shinobi Therapeutics CEO
Exclusive: Shinobi raises $51M to take on cell therapy challenges with ex-Wugen CEO at helm, Carl June in support
Shinobi Therapeutics is trying to live up to its moniker, named after the Japanese word for ninja.
The biotech — a merger of two startups from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
